| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |